The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding
Open Access
- 1 February 2007
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 282 (6), 3664-3671
- https://doi.org/10.1074/jbc.m609178200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2Published by Elsevier BV ,2005
- Evidence for a functional role of the second C5a receptor C5L2The FASEB Journal, 2005
- Identification of complement 5a‐like receptor (C5L2) from astrocytes: characterization of anti‐inflammatory propertiesJournal of Neurochemistry, 2005
- The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating ProteinJournal of Biological Chemistry, 2003
- Sulfated Tyrosines Contribute to the Formation of the C5a Docking Site of the Human C5a Anaphylatoxin ReceptorThe Journal of Experimental Medicine, 2001
- An Activation Switch in the Ligand Binding Pocket of the C5a ReceptorPublished by Elsevier BV ,2001
- Pharmacological characterization of antagonists of the C5a receptorBritish Journal of Pharmacology, 1999
- Identification of ligand effector binding sites in transmembrane regions of the human G protein‐coupled C3a receptorProtein Science, 1999
- Evidence that the extracellular N‐terminal domain of C5aR contains amino‐acid residues crucial for C5a bindingEuropean Journal of Haematology, 1993
- Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor bindingJournal of Medicinal Chemistry, 1992